Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

MRES Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: June 04, 2026

Report Source: 2026 1st Quarter Report

Institute of Biomedical Research Corp

Institute of Biomedical Research Corp. Stock Analysis MRES

United States N/A Nano Cap Report:
Institute of BioMedical Research Corp. engages in research and development, quality control and standardization of pharmaceuticals, cosmetics and food products. The company is headquartered in Niksic, Niksic. The company went IPO on 2000-10-27. The firm's services include scientific research and biomedical services, such as research and development, quality control, standardization of pharmaceuticals, cosmetics and food products. The firm also provides long-term biomedical and environmental research projects, develops new diagnostic biomedical technologies and experimental medical treatments. The firm's products include Aerosan, MicrobEX, Microbicidal Towels KleNET, OralNet, Oral Ocean Power and Purilair. The company offers electro medical devices, such as BioMed 2000 XT with Timer, BioStim INF, QuadStar Elite, QuadStar II, Pain Gone piezo-electric pain relief and Portable Ultra Sound Device. The company offers various services, including quality control services, regulatory services, healthcare services, environmental analyses, building decontamination, and environmental protection and management.
Read More

Institute of Biomedical Research Corp (MRES) Chart

Key Statistics of Institute of Biomedical Research Corp (MRES)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

21.30K

P/E Ratio (TTM)

-

52 Week Range

$0.00$0.02

Market Cap

4.67M

Avg. Volume

1.70M

Dividend Yield

-

Financial Metrics & Statements of Institute of Biomedical Research Corp (MRES)

FAQ's for Institute of Biomedical Research Corp (MRES)

  • According to Musaffa’s Shariah screening methodology, Institute of Biomedical Research Corp (MRES) is currently classified as HALAL as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Institute of Biomedical Research Corp using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Institute of Biomedical Research Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Institute of Biomedical Research Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Institute of Biomedical Research Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Institute of Biomedical Research Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.